LP
BMY icon

LMR Partners’s Bristol-Myers Squibb BMY Stock Holding History

LMR Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Sell
5,001
-12
-0.2% -$700 ﹤0.01% 1141
2025
Q4 		$270K Sell
5,013
-74,775
-94% -$3.6M ﹤0.01% 1230
2025
Q3 		$3.6M Buy
79,788
+24,788
+45% +$1.16M 0.02% 597
2025
Q2 		$2.55M Buy
55,000
+12,610
+30% +$619K 0.02% 599
2025
Q1 		$2.59M Sell
42,390
-89,777
-68% -$5.23M 0.02% 603
2024
Q4 		$7.48M Sell
132,167
-127,795
-49% -$7.14M 0.06% 300
2024
Q3 		$13.5M Buy
+259,962
New +$12.2M 0.11% 166
2021
Q4 		– Sell
-6,265
Closed -$371K – 1158
2021
Q3 		$371K Buy
+6,265
New +$413K ﹤0.01% 846
2021
Q2 		– Sell
-13,559
Closed -$856K – 1132
2021
Q1 		$856K Sell
13,559
-4,294
-24% -$267K 0.02% 519
2020
Q4 		$1.11M Sell
17,853
-1,497
-8% -$92K 0.02% 270
2020
Q3 		$1.17M Buy
+19,350
New +$1.16M 0.02% 193
2020
Q2 		– Sell
-52,413
Closed -$2.85M – 600
2020
Q1 		$2.85M Sell
52,413
-14,748
-22% -$901K 0.13% 94
2019
Q4 		$4.31K Buy
+67,161
New +$3.85M 0.01% 86
2019
Q2 		– Sell
-181,042
Closed -$8.64M – 440
2019
Q1 		$8.64M Buy
+181,042
New +$9.02M 0.44% 41
2017
Q4 		– Sell
-7,308
Closed -$465K – 332
2017
Q3 		$465K Buy
+7,308
New +$427K 0.05% 193
2016
Q4 		– Sell
-16,683
Closed -$900K – 330
2016
Q3 		$900K Sell
16,683
-310
-2% -$19.9K 0.09% 205
2016
Q2 		$1.25M Buy
+16,993
New +$1.2M 0.19% 150
2016
Q1 		– Sell
-15,588
Closed -$1.07M – 378
2015
Q4 		$1.07M Buy
+15,588
New +$1.03M 0.35% 60
2015
Q3 		– Sell
-18,065
Closed -$1.2M – 328
2015
Q2 		$1.2M Buy
18,065
+12,865
+247% +$848K 0.15% 203
2015
Q1 		$335K Sell
5,200
-7,112
-58% -$445K 0.05% 327
2014
Q4 		$727K Buy
+12,312
New +$694K 0.1% 247

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's BMY Position: Q1 2026 in Review

LMR Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.24% in Q1 2026, selling an estimated $700 and leaving 5,001 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

LMR Partners first reported a position in BMY in Q4 2014 and has held it in 21 quarters since. The position peaked at $13.5M in Q3 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LMR Partners held 5,001 shares of Bristol-Myers Squibb worth $303K as of Q1 2026.
  • LMR Partners sold 12 Bristol-Myers Squibb shares in Q1 2026, an estimated $700.
  • Bristol-Myers Squibb made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1141 holding.
  • LMR Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 21 quarters since.
  • LMR Partners's Bristol-Myers Squibb position peaked at $13.5M in Q3 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.